Pan Chen

Guangzhou, 510655, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Comparable Euploidy and Aneuploidy Patterns Between Utrogestan-Based Progesterone-Primed Ovarian Stimulation and GnRH Antagonist in PGT-M: A Retrospective Matched Cohort Study.

Comparable Euploidy and Aneuploidy Patterns Between Utrogestan-Based Progesterone-Primed Ovarian Stimulation and GnRH Antagonist in PGT-M: A Retrospective Matched Cohort Study.

Journal: Biomedicines

Published: April 28, 2026

Posaconazole mitigates α-amanitin-induced liver injury by inhibiting STT3B-mediated glycosylation and cellular uptake.

Posaconazole mitigates α-amanitin-induced liver injury by inhibiting STT3B-mediated glycosylation and cellular uptake.

Journal: Frontiers in pharmacology

Published: April 24, 2026

Free mycophenolic acid exposure for therapeutic drug monitoring in paediatric lupus nephritis: associations with treatment response and haematologic toxicity.

Free mycophenolic acid exposure for therapeutic drug monitoring in paediatric lupus nephritis: associations with treatment response and haematologic toxicity.

Journal: Lupus science & medicine

Published: April 10, 2026

Comment on: Predicting mycophenolic acid exposure in pediatric lupus nephritis: a real-world study across three clinical scenarios: reply.

Comment on: Predicting mycophenolic acid exposure in pediatric lupus nephritis: a real-world study across three clinical scenarios: reply.

Journal: Rheumatology (Oxford, England)

Published: April 02, 2026

Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases.

Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases.

Journal: Frontiers in pharmacology

Published: March 27, 2026

Models Integrating Disease Heterogeneity and MPA Exposure Predict Systemic and Renal Efficacy of Mycophenolate in Pediatric Lupus Nephritis.

Models Integrating Disease Heterogeneity and MPA Exposure Predict Systemic and Renal Efficacy of Mycophenolate in Pediatric Lupus Nephritis.

Journal: Pharmacotherapy

Published: November 14, 2025

Advancing pharmacist involvement in surgical prehabilitation: a call to action for global pharmacy practice.

Advancing pharmacist involvement in surgical prehabilitation: a call to action for global pharmacy practice.

Journal: International journal of clinical pharmacy

Published: October 25, 2025

Donor and recipient genetic polymorphisms modulate tacrolimus pharmacokinetics during voriconazole co-therapy: a drug-drug interaction study in liver transplant recipients.

Donor and recipient genetic polymorphisms modulate tacrolimus pharmacokinetics during voriconazole co-therapy: a drug-drug interaction study in liver transplant recipients.

Journal: Therapeutic advances in drug safety

Published: October 03, 2025

Expert consensus on the off-label use of drugs for pediatric rare diseases in China (2025 edition).

Expert consensus on the off-label use of drugs for pediatric rare diseases in China (2025 edition).

Journal: Translational pediatrics

Published: August 04, 2025

Optimizing mycophenolic acid exposure for reduced relapse risk in paediatric nephrotic syndrome: An observational cohort study.

Optimizing mycophenolic acid exposure for reduced relapse risk in paediatric nephrotic syndrome: An observational cohort study.

Journal: British journal of clinical pharmacology

Published: August 01, 2025

Predicting mycophenolic acid exposure in paediatric lupus nephritis: a real-world study across three clinical scenarios.

Predicting mycophenolic acid exposure in paediatric lupus nephritis: a real-world study across three clinical scenarios.

Journal: Rheumatology (Oxford, England)

Published: July 01, 2025

Reply to: Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes.

Reply to: Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes.

Journal: Seminars in arthritis and rheumatism

Published: March 27, 2025

Showing 1-12 of 80

Last Updated: 09/26/2026